Expanding the Target Landscape by Drugging the Undruggable (R21 Clinical Trial Not Allowed)

Skip to main content

Contracts Grants Pricing Blog Glossary

Loading...

Kontrakk

The only workspace built for the work of government contracting.

Platform

Discovery feed
Pursuit board
Grants

Industries

Federal contractors
Defense primes
Nonprofit grants
Higher education

Resources

Help center
Developer docs

Company

About
Privacy
Terms of Service

© 2026 Kontrakk. All rights reserved.Government Contracts. Won with Confidence.

Expanding the Target Landscape by Drugging the Undruggable (R21 Clinical Trial Not Allowed)

Home
Grants
Expanding the Target Landscape by Drugging the Undruggable (R21 Clinical Trial Not Allowed)

Expanding the Target Landscape by Drugging the Undruggable (R21 Clinical Trial Not Allowed)

posted

synopsis

#PAR-25-442

Agency

National Institutes of Health

Code: HHS-NIH11

Description

No description available

Important Dates

Open Date

Jun 17, 2025

Close Date

Feb 17, 2028

CFDA Numbers

93.350

93.121

93.867

93.855

93.865

93.242

View on Grants.gov

More grants from National Institutes of Health

Investigator-Focused Award (Parent R35)
National Institutes of Health
Advanced Development and Sustainment of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)
National Institutes of Health
INCLUDE Project: Omics Phenotypes Related to Down Syndrome (X01 Clinical Trial Not Allowed)
National Institutes of Health
Clinical and Translational Science Award
National Institutes of Health
Limited Competition: Institutional Mentored Research Career Development Program for the Clinical and Translational Science Awards Program
National Institutes of Health